Skip to main content

TAKEDA PHARMACEUTICAL CO LTD

Location
Tokyo, M0
Portfolio Value
Micro $16,369,652
Diversification
Highly concentrated
Reports for
Takeda Vaccines, Inc.
Filing Date
Global Rank
#7,968 / 8,106 ▲ 83 · as of Sep 2025
Top Industry
Biotechnology 96.9%
Period ended 1 year ago
Filed Nov 13, 2025 · 11mo
8 quarters · since Dec 2023

Regulatory profile

From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.

Holder type
Unknown
SIC code
2834

Portfolio style

Measured from the filed 13F common-share book for Sep 30, 2025, never from the firm's own description.

Style
Concentrated
The top 10 positions are 100.0% of the book (60%+)
Turnover
Low turnover
4.4% over the last four quarters (under 30%)
Horizon
Medium horizon
Value-weighted holding period 7.8 quarters (4 to under 12)

Closest benchmark: the Russell 2000 as of 2025-09-30, active share 100.0%; sector active share 90.8% against the combined 13F book's sector weights.

Over time 8 measured quarters

How the bands are measured

Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

8 tracked positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025
Top Position
59.8%
+15.9 pts
Top 5
96.3%
+5.0 pts
Top 10
100.0%
0.0 pts
HHI
3,985
Dec 2023 → Sep 2025 · range 2,274 – 5,659
Highly concentrated+1,390

Portfolio Trend

8 quarters · across all stocks

Sector Breakdown

As of Sep 30, 2025
Sector % Portfolio Value
Healthcare 100.0% $16,369,652

Last Quarter's Activity

Export CSV
Sep 30, 2025 vs Jun 30, 2025

Added To

Positions the filer increased
1 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
No qualifying positions this quarter.

New Positions

Positions the filer opened this quarter
No qualifying positions this quarter.

Sold Out

Positions the filer fully exited
3 positions
Ticker Shares Value Open
— 6,724,000 $0
— 895,824 $0
— 36,835 $0

Portfolio Positions

Export CSV View 13F filing
8 tracked positions · $16,369,652 total · filing declares 9 positions · $16,369,175 · as of Sep 30, 2025
Ticker Company Shares Value (USD) % of Portfolio History

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.